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Abstract 
This study evaluated five extracellular polymers of bacterial origin possessing mucoadhesive properties for 
their antimicrobial properties and toxicological characteristics. Of the five tested mucoadhesive biopolymers, 
the extracellular polymer produced by a strain of Acinetobacter haemolyticus exhibited broad antimicrobial 
efficacy towards Yersinia enterocolitica, Salmonella typhimurium, Listeria monocytogenes, Escherichia coli 
O157:H7 and Bacillus subtilis. Significant (p<0.05) inhibition of gram negative bacterial pathogens followed by 
gram positives were observed with the biopolymer at a dose of 40-60 μg ml-1 at ambient temperature. The 
cytotoxicity under in vitro conditions and oral toxicity in murine models was also evaluated. The biopolymer 
did not elicit either haemolytic activity or toxicity in RAW 264.7 cell lines. Haemotological, histopathological 
and general examinations indicated no adverse effects in Swiss albino mice fed with the biopolymer (120 mg 
kg-1 body weight-1 day1) over a period of 30 days. These results suggested that the biopolymer was well 
tolerated without any signs of toxicity and may have several potential biomedical applications where 
disinfection is desired. 
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1. Introduction: 
In the past three decades an increasing number of reports described the bioactivities of polysaccharide glucans 
and proteoglucans from plant and other sources highlighting the potential use of this class of molecules for 
immune stimulatory properties. The novel structures and diverse biological activities of microbial 
exopolysaccharides, lacking in plant polysaccharides have prompted the application of microbial exopolymers 
in potentially important industrial and biomedical areas. The significantly expanded scope of exopolysaccharide 
for commercial applications over the current years is based on strong insights on their diverse technological and 
putative environmental functionalities [1,2]. Additionally, biopolymers represent a low environmental impact 
technology for applications in a wide sphere of human activities including drug delivery vehicles. 
Mucoadhesive polymers have recently gained a great deal of attention, in pharmaceuticals, in view of their 
potential in increasing residence time [3,4,5] and maintaining a high concentration gradient of drug across the 
epithelium [6]. The usefulness and the ultimate bioavailability of a drug, to an extent, are determined by the 
length of time it is present at or in the desired site of action. The attribute of mucoadhesiveness can increase the 
 residence time and hence potentially enhance the bioavailability of a drug. Additionally, mucoadhesives have 
proven to increase the permeability of the epithelial wall [7]. This has been explained by their tendency to 
dehydrate the mucous layer causing the cells of the epithelium to ‘shrink’ and hence open up the tight junctions. 
Our earlier studies yielded through extensive screening, potential exopolymer producing bacterial isolates from 
diverse source resulting in an exopolymer library. Characterization of these bacterial exopolymers led to the 
selection of five biopolymers with reasonable mucoadhesivenesss (unpublished observations). 
The emerging interest to create safe, cost-effective biomaterials as non irritant, non toxic  biocidals for human 
applications. While the intrinsic antimicrobial properties have been sought as intriguing feature in biopolymers, 
few biopolymers with mucoadhesive properties have been characterized with inherent, broad antimicrobial 
spectrum. Therefore we sought to explore these microbial exopolymers with antimicrobial potential preferably 
against both gram positive and negative bacterial pathogens. A key aspect for viability of biopolymers relies on 
their toxicity profile and requires to be addressed through well designed studies. The antimicrobial properties of 
biopolymers exhibiting mucoadhesive properties and produced by bacterial isolates was evaluated for  their 
antimicrobial activity; the in vitro cytotoxicity of the prospective exopolymers determined using the RAW 
264.7cell lines and  oral toxicity investigated in murine models are reported in this study. 
2. Materials and methods  
2.1. Biopolymer source: 
The  exopolymers were extracted from their respective bacterial cultures (Acinetobacter 
haemolyticus,KP701480; Bacillus subtilis, KX610831; Paenibacillus thiaminolyticus, KX588229; Trabulsiella 
odontotermitis, KX588299 and Paenibacillus lentomorbis, KX608547) 
by cultivating them in 2 L of FIB medium on a rotary shaker (120 rpm/min) at 30°C for 48 h as described 
earlier [8,9]. Bacterial cells were removed by centrifugation at 12,000 g for 30 min at 4°C and polysaccharide 
was separated from the supernatant by the addition of two volumes of ethanol and precipitation at 4°C for 24 h. 
The precipitated polysaccharide was collected by filtration (Whatman GF Filter), dissolved in deionized water, 
dialyzed extensively against deionized water and lyophilized. Crude exopolysaccharide was dissolved in 
deionized water and re-precipitated by adding a 10% solution of cetylpyridinium chloride (CPC). The 
precipitated polysaccharide complex was collected by centrifugation at 10,000 g for 20 min at 4°C and re-
dissolved in a 10% NaCl solution. The precipitated polysaccharide was recovered by addition of three volumes 
of ethanol. The extracted polysaccharide was dissolved in deionized water, dialyzed twice against deionized 
water and lyophilized. The biopolymers were designated as TK15, W2B, X4, P8, Z3 respectively.  
2.2. In vitro Antimicrobial Activity and Cytotoxicity of the Molecules 
Antimicrobial activity of exopolysaccharides (EPS) was assayed against Aeromonas hydrophila ATCC 7966, 
Yersinia enterocolitica MTCC 840, Salmonella typhimurium ATCC19585, Listeria monocytogenes ATCC 
19111and E. coli O157:H7 ATCC 43895,  Bacillus subtilis ATCC 6633, Staphylococcus aureus ATCC 6538 
and Pseudomonas aeruginosa ATCC 9027. The plate well diffusion method was used to visualize the 
formation of a zone of inhibition in a TSB (tryptic soy broth) solid culture medium.  
Approximately 0.25 ml of biopolymer for used for all pathogens, 50 µl suspensions of which were spread onto 
 plates and the plates incubated for 24 h at 37
0
C for microorganism growth. Inhibition zones were then 
measured on bases of the average diameter of the clear area, directly on the dishes. 
  Antibacterial activity of biopolymer TK15 was assayed by microdilution method, using a sterile 96 well-microtiter 
plate reader (Bioscreen C, Thermo labsystems, Helsinki, Finland)  (Raafat  et  al.  2009).    Briefly, the growth of 
indicator organisms in broth (300µl) containing biopolymer in different concentrations was studied in micro titre plates 
(100 wells). Each well was inoculated with 10µl broth culture (grown overnight) of the test organism diluted to about 
106CFU/ml adjusted as McFarland standard. The optical density at 600nm was measured automatically at 10min 
interval, using a wideband filter (405-600nm), and the plates were shaken at 3min interval for 20s. Viable counts were 
performed by withdrawing aliquots in duplicate followed by serial dilution and plating onto TSA, subsequent 
incubation for 18-24 hours at 37 0C and recording colony counts. The MIC was defined as the lowest concentration 
of biopolymer required to completely inhibit microorganisms [10].  
EPS cellular toxicity was evaluated by hemolytic assay [11] using sheep blood cells (BioMérieux, France). 
Control experiments comprised similar combinations but lacked biopolymer. Percentage hemolysis was 
calculated as under: 
   Haemolysis %=  O.Ds-O.Dnc 
                               O.Dpc-O.Dnc 
Where,   ODs,   ODnc,    ODpc    are   optical   densities  of sample, negative 
control and positive control respectively. 
 To determine the cytotoxic activity of the microbial exopolymers on macrophages, RAW 264.7 cells (1 × 10
4
 
cells/mL) were cultured in Dulbecco’s modified Eagle’s medium (DMEM; HIMEDIA,Mumbai, India) 
supplemented with 10% fetal calf serum, 1% penicillin-streptomycin solution,1% L-glutamine and HEPES[4-
(2-hydroxyethyl)-1-piperazineethanesulfonicacid] in a 96-well plate at 37°C in an atmosphere of 5% carbon 
dioxide (CO2) for 24 hours, followed by treatment of the cells with different concentrations of biopolymers for 
another 24 hours. To determine the cell viability, MTT (at a concentration of 0.1 mg/mL) was added to the 
wells and incubated for 4 hours at 37°C in an atmosphere of 5% CO2 in the dark. In metabolically active cells, 
MTT was reduced to an insoluble, dark purple formazan. The formazan crystals were dissolved in dissolving 
buffer (sodium dodecyl sulfate[SDS] [11 g] in 0.02 M hydrochloric acid [HCl] [50 mL]and isopropanol [50 
mL]). The absorbance was read at 570nm. 
2.3 Oral toxicity 
Biopolymer solutions were prepared with sterile distilled water and kept under refrigeration until use. The 
toxicity studies were carried out in accordance with the OECD guidelines 423 (OECD).. Twenty-five pathogen-
free male Swiss mice (8 weeks old) were acclimatized to a 12/12 h light/dark cycle for 1 week. They were 
housed in a polystyrene cage, allowed free access to feed and sterile tap water, divided into five groups of five 
animals per cage and identified. The biopolymer was administered orally at a dose of 25, 75, 120 and 140 mg 
kg-
1
 in distilled water for 30 days. The control group received sterile distilled water. The animals were observed 
for mortality and morbidity such as convulsions, tremors, grip strength and pupil dilation. All animals were 
weighed before treatment, weekly during treatment and at the end of the study. The feed consumption was 
recorded weekly. 
 2.4 Haematology 
At the end of the experiment, animals were anaesthetized in an ether chamber, and blood was collected by 
cardiac puncture. Analysis of red blood cell count (RBC), haematocrit (Hct), haemoglobin concentration (Hb), 
mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin 
concentration (MCHC) and differential cell count were conducted. 
2.5 Histology 
Necropsies were performed on all study animals; the liver and kidney were analyzed macroscopically. In order 
to microscopically examine the tissues, the latter were fixed 
in aqueous Bouin, processed, embedded in paraplast, sectioned to a thickness of 7 μm, and stained with 
haematoxylin and eosin. Histological analysis of organs was done as described by [12] 
2.6 Statistical analysis 
Data was presented as mean± SD of three independent experiments. During the 30-day oral toxicity studies, 
treated and control groups were compared by ANOVA with significance level of 5 % using Statistica 11.01, 
(2012). 
3. RESULTS 
 In a prior study, the mucoadhesive properties of five biopolymers were evaluated by texture analysis and 
rheology and compared these with three established biopolymers: chitosan, pectin and sodium alginate, using 
rheological methods.  
Tensile test offers a better method of assessment on the strength of mucoadhesion as shown by the tested 
mucoadhesive polymer with mucin layer. The higher peak force indicated the higher interaction capability of 
mucoadhesive polymer. Additionally the total of work or area under curve suggested the ability of the 
mucoadhesive polymer to withstand the continuous forces (Table1a). 
 
The comparative rheological profile of the biopolymer TK15 depicting apparent, observed viscosity with 10% 
mucin is presented in Table 1(b)  Based on the value of viscosity synergism and normalized parameter, the rank 
order of mucoadhesion for the biopolymers tested was found to be sodium alginate > Chitosan > TK15. We 
observed that several factors such as concentration, contact time and ionic strength could affect the 
mucoadhesive property. These findings were similar to those reported earlier [13]. Since the mucoadhesiveness 
of the 4 other biopolymers were lower in rank than TK15, the latter was selected for further studies.  
 
 Antimicrobial activity: 
TK15 demonstrated notable inhibition and its potency against both gram positive and gram negative bacterial 
pathogens tested as shown in Fig 1 (a). The antimicrobial activity of the biopolymer was evident over an 
average concentration range of 40-80 µg/mL. Further increase in concentration failed to alter the antimicrobial 
efficacy significantly (p>0.05).In liquid media, inhibition could be clearly observed (Table 1 a, sup) after 10 
minutes. Over 4 log reduction was evident after 30 minutes in all cases. The inability of re-growth of each 
pathogen, if any, following injury was confirmed using TAL (Thin agar layer plates, results not shown). Gram 
positive pathogens required higher doses (80µg/mL) of the biopolymer.  
  Molecular identification of strain TK 15 
Molecular characterization of the producer bacterial isolate was performed by 16S rRNA sequencing using 
universal primers. The TK15 DNA was extracted, amplified and 16S rRNA PCR products were sequenced and 
aligned by multiple sequence alignment. Based on the phylogenetic tree constructed with sequences of 
representative bacteria, the  strain which  was isolated from the  effluents of a textile dyeing unit, was ascribed 
to genus Acinetobacter and species haemolyticus (Fig.1); the sequence of this strain has been deposited in 
GenBank database (Accession No KP701480).  
Biochemical characterization of biopolymer TK15: 
Pentoses were identified as the second major components in addition to amino sugars, uronic acid and pyruvic 
acid which constituted approximately 15% weight fraction of the biopolymer, while DNA and RNA were not 
detected. FTIR analysis (Fig.2) of TK15 revealed presence of a broad peak characteristic of stretching vibration 
of hydroxyl (O-H) and amino (N-H) groups at 3408 cm
-1
. The peak at 1650 cm
-1 
represents N-H bending of 
primary amines while the peak at 1421 cm
-1
represents C-N stretching of amines. The peak at 1032 cm
-1 
was 
attributed to CO ether linkage of sugars while the peak at 875 cm
-1
indicated presence of β glycosidic linkage in 
the biopolymer TK15. 
Cytotoxicity: ASTM F 756-00 (2000) classifies materials into three categories based on their hemolytic   index. 
Those exh ib i t ing>5% hemolysis are considered hemolytic, between 2-5% are considered slightly hemolytic 
while those having<2% hemolysis are non hemolytic materials [16].Haemolysis observed by TK 15 was less 
than 2% indicating a strong possibility for being safe. The risk of hemolytic character is evaluated against the 
clinical benefits. To further substantiate the finding, RAW 264.7 cells were challenged with various 
concentrations of this biopolymer. The cell viability was not significantly affected at 24 hours of incubation in 
the presence of the biopolymer (Table 3).  Microscopic observations of the treated macrophages were also 
carried out. The macrophage cell morphology in a monolayer culture after the treatment with varying 
concentrations of TK15 exhibited no distinct morphological changes in the cells treated with the bactericidal 
doses (results not shown) even upon incubation for 48-72 hours. 
 
3.1 Oral toxicity studies 
Mortality of animals was not observed over the period of experiment. Body weight gains (Table 4 a), rectal 
temperature profile (results not shown) and feed consumption in all concentrations of the biopolymer tested was 
comparable to control group values. Behavioral changes or changes in body weight of TK15 exposed mice were 
not observed. Gross and microscopic examination revealed no changes attributable to the administration of 
either of the biopolymers. Haematology indicated no significant (p> 0.05) treatment related changes that were 
evident during the experimental period (Tables 4b and 5) upon comparison to the control group. Liver sections 
from mice fed with biopolymers exhibited a similar profile as the blank groups in liver tissues, suggesting the 
absence of any untoward response. 
  
4. DISCUSSION 
Rheological technique which studies the flow and deformation of materials (fluid) under applied stress is useful 
in determining the mucoadhesion ability of biopolymers. In this technique, mucin is used as the adherent 
substrate surface onto which the biopolymer would adhere. The technique indirectly assesses the interactions 
between the biopolymers and mucin through the measurements of viscosity and viscoelasticity. The parameter 
ηenh (viscosity enhancement or viscosity synergism) characterizes the strength of interaction between the 
biopolymers with mucin[14].The mucoadhesiveness of the biopolymers were evaluated using  this rheological 
technique as well as for their tensile strength in a prior study. Tensile test results indicating high peak force and 
total area under curve were in agreement to our observations from rheological experiments and indicated the 
intrinsic capability of biopolymer TK15. 
 In view of this, we extended our investigations further to evaluate the antimicrobial potential and safety of this 
biopolymer. Amongst the few biopolymers investigated for antimicrobial applications as well safety, chitosan 
has been extensively reported in a number of biomedical applications, including drug-delivery systems, tissue 
engineering and healing; Pullulan, a neutral linear polysaccharide composed of (1→6)-linked α-D-maltotriose 
residues synthesized from starch or sugar by the microorganism Aureobasidium pullulan, has adhesive 
properties and safety but lacks potential antimicrobial properties.  
     The TK 15 bipopolymer was characterized to be a polysaccharide with molecular weight of 48.9 kDa, 
composed of hexoses and pentoses in equal proportions. Although pentose sugars have been reported in small 
amounts in exobiopolymer produced by A. baumannii strains [16], the significant contribution of pentoses 
(approximately 50%) to polysaccharide composition suggests that A. haemolyticus TK 15 is unique as 
compared to other members of Acinetobacter genus.  
Bonding to the mucin layer or mucoadhesion of polymers   has been explained by several theories [26]. 
Amongst the key factors responsible for binding by an ideal polymer, the molecular weight, spatial arrangement 
and hydrogen bonding (presence of hydroxyl, carboxyl and amino groups) may be primarily responsible for 
binding of TK 15 biopolymer to mucin layer. Moreover, scanning electron micrographs have indicated the   
biopolymer to be a highly porous structure and ability to form hydrogels which may have implications in drug 
targeting and bioavailability of poorly water soluble drugs and for designing sustained release drugs[27, 28].  
The agar well diffusion assay offers a visual method for checking the local inhibition; therefore this was used 
initially to confirm the antimicrobial activity of the biopolymer for each pathogen. With liquid culture, we 
observed little or no increase of antimicrobial property at concentrations higher than 80µg biopolymer. It may 
be hypothesized that the formation of hydrogen and covalent bonds amongst the functional groups of 
biopolymer is facilitated at higher concentrations. The spatial restrictions borne upon the functional groups [22] 
in such cases, afford fewer charged sites available for interaction with the bacterial cell wall. In fact similar 
results have been shown with chitosan as well as chemically modified chitosan recently [23]. The complete 
inactivation of the pathogens   after a period of 30 minutes was interesting, however the dose requirements of 
 gram positives lay in a higher range of 80µg/mL; possibly the inherent architectural features assumed 
importance in this case. 
The observed antimicrobial properties of the biopolymer TK15 may be attributed to phenolic and or carboxylic 
groups or to the presence of short peptides strongly associated with the polymer.  
The antimicrobial mechanism may be explained by considering that the Gram-negative cell wall is thinner and more 
electronegative which facilitates effective binding. This results in blocking of nutrient flow and consequently 
enhanced susceptibility to lysis. On the other hand, cell walls of Gram bacteria positive bacteria are made up of 
peptidoglycans which contain N-acetyl glucosamine, N-acetyl muramic acid, D and L- aminoacids, glutamate and 
teichoic acid. These positively charged amino acids can bind with the biopolymer resulting in the cell wall 
distortion, exposure of cell membrane to osmotic shock and exudation of cytoplasmic contents [19,21]. 
Recently, gum tragacanth a high arabinose, protein containing acidic heteropolysaccharide was shown to 
possess antimicrobial activity against K.pneumoniae and C.albicans; the active index (AI) in comparison to 
standard antibiotics of this biopolymer was notably higher than when compared to guar gum for bacterial 
pathogens [15].  
Cationic polymers like chitosan have been shown to interact with the anionic membrane of the bacterial cells 
thereby initiating cell disruption [17]. Moringa seed polymer a cationic  polypeptide  acts directly and non-
specifically upon bacterial membranes causing leakage of cytoplasmic content whereas, polymers from Gum 
acacia contains cyanogenic glycosides that exhibit antibacterial properties [18]. It is possible that the presence 
of amino and carboxyl groups in TK15 play an important role in their antimicrobial property, however more 
detailed studies are necessary for understanding the exact mechanism of the bactericidal activity of this 
biopolymer.  
 An important aspect for any molecule to be used as an antimicrobial agent is that the molecule should be 
capable of eliminating the target pathogen without affecting the viability of mammalian cells. The RAW 264.7 
has been extensively used for screening the cytotoxicity of plant and microbial biopolymers apart from 
bioactives, with reliable interpretations [24].The MTT assay was used to test the cytotoxicity of TK15 
biopolymer treated macrophages. The MTT assay relies on the fact that metabolically active cells reduce MTT 
to purple formazan; hence, the intensity of dye read at 570 nm is directly proportional to the number of viable 
cells. However, the IC50 values could not be determined even after exposure of the macrophages to the 
biopolymer at the maximum concentration of 80µg/mL and after 72 hours incubation.Plant 
bioactives/biopolymers are considered to be cytotoxic is less than 20 mg/mL [25].Additionally, in agreement 
with the viability results, microscopic observations of the treated macrophages displayed a distinct morphology 
as that of control cells indicating the non toxicity of TK15. Therefore the non cytotoxic nature of the 
biopolymer was concluded from these observations.  
 
   Elaborate documentation for the safety of polysaccharide biopolymers intended for human applications have 
been suggested; for instance chitins from crustacean shells [19] β-glucan from barley and yeast [20, 21] have 
been extensively evaluated. A general interpretation from these studies highlight that differences in the 
molecular structures of polysaccharide chains (e.g., chain length, type of linkage) in biopolymers influence 
 physico-chemical properties and, consequently, biological activity as well as a differential response in mice 
under in vivo conditions (intestinal behavior); however, these biopolymers were destined as dietary 
supplements. Such detailed examination, including caecum, urine and faeces, was not deemed important since 
the present study was designed to judge the toxicity of the antimicrobial polymers. The absence of lipids and 
the presence of a primarily polysaccharide composition of TK15, eliminated the possibility of a cytotoxic effect 
as indicated in toxicity studies with cell lines. A critical comparison of the results obtained from our studies was 
not possible due to the lack of similar studies, where microbially derived biopolymers have been screened for 
antimicrobial property. The absence of negative effects of the biopolymers on behavior, body weight, 
haematology and organ histology at higher concentrations through oral route representing 1,000-fold more than 
the anticipated application suggest the safety, and therefore, a potential applicability of the biopolymer. To the 
best of our knowledge, extracellular polymers of microbial origin as well as antimicrobial properties with 
mucodahesive attributes have not been reported. Given its safety and intrinsic characteristics we presume 
potential applications of TK15; further studies regarding its other functions are currently underway. 
5. Conclusion 
 TK15, an extracellular polymer with mucoadhesive properties, produced by Acinetobacter haemolyticus 
demonstrated potential antimicrobial characteristics against both gram positive and gram negative bacterial 
pathogens under in vitro conditions. The biopolymer was non haemolytic and non cytotoxic as evident from 
results of in vitro toxicity tests. Oral toxicity of the biopolymers in murine models suggests its safety for up to a 
concentration of 40-80 µg/mL. The promising functionalities of this biopolymer and its safety obtained from 
the results of this study imply an interesting commercial prospect for its further exploitation. 
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Fig 1: Phylogenetic tree of the mucoadhesive biopolymer TK 15 
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 Fig 1(a) : Antimicrobial activity of biopolymer TK15 against selected pathogens(A) Aeromonas hydrophila (B) Salmonella 
typhimurium (C) Listeria monocytogenes  and (D) Staphylococcus aureus.Indicator pathogens are on the left  and control on 
right. 
(A)                                                         (B)                                                         (C) 
 
  
 
                      (D)
 Fig 2: FTIR spectra of the mucoadhesive biopolymer TK 15 
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Table 1(a): Apparent viscosity and observed viscosity of the different polymers and their mixture with 
10% (w/v) mucin (1.5 ml of polymer solution used for the mixing process) at 50 s-1, 5 minutes holding 
time at ambient temperature. 
 
 
Biopolymer Biopolymer 
concentration 
Ηp η obvs η exp η enh 
 (w/v)     
Sodium 1% 0.023  + 0.02 1.30 + 0.3 0.43 +0.05 0.871+ 0.04 
Alginate 
High DE 
 
1% 
 
0.017±0.01 
 
1.323+ 0.51 
 
0.432+0.07 
 
0.891+0.09 
Pectin 
TK15 
 
1% 
 
0.024±0.001 
 
1.283 +0.33 
 
0.438 +0.06 
 
0.845+0.08 
Mucin 0 0.00079+0.002 0.414+0.08 0.414 +0.04 0 
 
 
Table 1(a): Total work (area under curve) of tensile test for different of concentrations and biopolymers. Tensile 
strength was determined by a texture analyzer. Figures in parentheses indicate standard deviation of mean. 
 
 
Biopolymer MP(g.s) WP(g.s) MW(g.s) Net(g.s) Normalized 
parameter 
1% Sodium 
alginate 
2149.64+57.12 46.87+11 26.75+13 256+20 3.5 
2%Sodium 
alginate 
3227.34 + 61 98+12.02 26+11.5 491+31 3.93 
1% Pectin  1039.23+ 97 7.25+3.3 421+20.7 612+33 1.81 
2% Pectin  2446.14 + 107 730.77+21 421.38+24 1297.69+113 1.13 
1% TK 15 2045.23 +112 44.7+13 22.4+13 251+43 3.1 
2% TK15 3132.21+  139 99+14 23+11  483+37 3.7 
 
  
 
 
 
 
 
 
 
 
 
 
 
Table 2: Zones of Inhibition of selected bacterial pathogens observed with different concentrations of the 
biopolymer TK15 
 
 
Indicator 
pathogen 
10µg 20µg 40µg 60µg 80µg 
Yersinia 
enterocolitica 
9.6mm 12.5mm 17mm 16.5mm 16.8mm 
Salmonella 
typhimurium 
10mm 9.6mm 16mm 15.3mm 14mm 
Listeria 
monocytogenes 
10mm 8.8mm 14.3mm 15.0mm 14.7mm 
Escherichia coli 
O157:H7 
11.4mm 11mm 14mm 13.7mm 13.5mm 
Bacillus subtilis 11mm 10.7mm 11.6mm 12mm 11.3mm 
Pseudomonas 
aeruginosa 
8.7mm 10mm 13mm 12.2mm 12mm 
 
 Table 3: Cytotoxic effect of the biopolymer TK 15 in murine macrophages. 
 
 
 
Biopolymer dose Cell Viability 
 
 
 
10 98.2% + 5.3 
20 98% + 4.8 
40 98.3% + 5.2 
60 99% + 8.8 
80 98.6% + 7.5 
Control 100% + 9.6 
 
Table 4(a):  Mean body wt profile after every 5
th  
day of administration of TK15 
 
 
Group Dose Days     
 (mg/Kg 
bw 
0 5 10 15 20 25 30 
G1 60 23.5 + 23 + 24 + 24 + 23.5 + 23.4 + 23.3 + 
G2 180 23.0 + 22 + 22.5 + 23.5 + 23.0 + 22.8 + 22.8 + 
G3 220 23.0 + 22.5 + 23.4 + 22.2 + 22.6 + 23.5 + 23.2 + 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 4(b): Means of red blood cell parameters in mice administered biopolymer by gavage for 30 days, 
TK15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Parameter 
Dose 
0 
 
25 
  
80 
 
120 
 
140 
Red blood cells       
(millions/mm3) 9.0±   0.2 7.4 ± 0.2 6.5   ± 0.9 7.0   ± 1.5 8.3  ± 0.2 
Haemoglobin (g dL 1) 13.1± 2.0 13.3 ± 1.2 46± 1.2 15.4 ± 2.4 18.5 ± 3.5 
Haematocrit(%) 
Mean corpuscular volume 
49.3± 5.3 53 ± 3.8 51 ± 3.4 50 ± 5.1 48.7 ± 2.0 
(μm3) 
Mean corpuscular 
50.8± 2.2 60 ± 10.5 46 4± 7.3 63.2 ± 10.5 50 ± 2.3 
haemoglobin (pg) 
Mean corpuscular haemoglobin 
17.2± 0.7 18.2 ± 1.0 21 ± 3.0 20.5 ± 2.5 21.9 ± 4.0 
concentration (%) 28.2± 4.3 25 ± 4.8 26 ± 4.2 30 ± 2.5 39 ± 9.3 
 
 
 
Table 5: Means of white blood cell parameters of mice administered TMB by gavage for 30 days, 
TK 15 
Parameter (%) 0 5 15 25 35 
 
 
Eosinophils 0.8  ± 0.9 1.3 ± 0.7 1.6 ± 0.6 1.4 ± 1.0 1.34± 0.6 
Monocytes 4.4± 1.0 4.8 ± 1.5 4.8 ± 1.2 4.2 ± 1.5 4.2± 1.6 
Lymphocytes .07± 2.5 83 ± 6.4 8.8 ± 3.0 80.3 ± 7.2 80.1± 8.5 
Neutrophils 1.2  ± 2.0 13 ± 4.2 1.4 ± 4.1 12.3 ± 8.2 13.02± 4.2 
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Table 6: Chemical Composition of TK15 1 
 2 
 3 
Constituent  
Sugars 74.2 
Proteins 8 
Amino sugars 2.5 
Pyruvic acid 0.98 
Uronic acids 2.1 
DNA ND 
RNA ND 
Carbon 18.7 
Hydrogen 4.35 
Nitrogen 6.14 
Sulphur` 0.2 
 4 
 5 
